NTRK3 and neoplasm: To determine whether the TrkC contributes to the primary tumor formation of ES cells in vivo, we implanted TrkC expressing control or TrkC-shRNA-engineered TC252 cells subcutaneously in BALB/c Nu/Nu mice and analyzed the formation of primary tumors.